human
infect
middl
east
respiratori
syndrom
coronaviru
merscov
driven
recur
dromedarytohuman
spillov
event
lead
decisionmak
consid
dromedari
vaccin
dromedari
vaccin
candid
develop
pipelin
show
hope
result
gap
understand
epidemiolog
merscov
dromedari
must
address
design
evalu
potenti
vaccin
strategi
systemat
review
publish
literatur
report
seropreval
andor
preval
activ
merscov
infect
dromedari
popul
crosssect
longitudin
studi
includ
studi
qualit
synthes
merscov
seropreval
increas
age
adult
dromedari
support
geograph
wide
spread
endem
merscov
dromedari
arabian
peninsula
countri
export
dromedari
africa
high
preval
activ
infect
measur
juvenil
site
dromedari
popul
mix
guid
investig
particularli
dromedari
movement
inform
vaccin
strategi
design
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
studi
howev
vaccin
strategi
evalu
current
preclud
gap
understand
epidemiolog
merscov
dromedari
dromedari
popul
highli
heterogen
span
wide
geograph
area
stretch
west
africa
middl
east
part
asia
know
dromedari
would
need
target
like
impact
vaccin
necessari
consider
dromedari
vaccin
wider
socioeconom
cultur
context
systemat
review
publish
studi
measur
merscov
antibodi
seropreval
dromedari
andor
preval
viral
rna
dromedari
assum
assay
specif
longterm
presenc
antibodi
infect
seropreval
use
estim
proport
dromedari
popul
ever
infect
merscov
broken
age
class
tell
us
anim
encount
infect
first
time
addit
although
wholeviru
isol
cultur
necessari
confirm
whether
shed
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
avail
took
result
neutralisationbas
test
method
determin
seroposit
base
antibodi
screen
test
alon
neutralis
antibodi
test
specif
world
health
organis
recommend
method
confirm
merscov
seroposit
sinc
first
human
case
middl
east
respiratori
syndrom
coronaviru
merscov
infect
detect
substanti
evid
base
built
show
dromedari
camel
zoonot
sourc
viru
merscov
circul
extens
dromedari
popul
caus
impact
diseas
human
infect
howev
associ
measur
case
fatal
ratio
around
follow
spillov
event
humantohuman
transmiss
merscov
rel
ineffici
limit
close
unprotect
contact
environ
hospit
phylogenet
analysi
viral
sequenc
isol
dromedari
human
indic
hundr
cameltohuman
spillov
event
like
occur
sinc
taken
togeth
recur
dromedarytohuman
transmiss
drive
ongo
human
infect
key
role
dromedari
human
merscov
infect
led
decisionmak
consid
dromedari
vaccin
part
merscov
prevent
intervent
dromedarytarget
vaccin
candid
develop
pipelin
show
promis
result
includ
orthopoxviru
base
vaccin
capabl
greatli
reduc
viral
shed
dromedari
challeng
infecti
detect
viral
rna
rtpcr
use
proxi
preval
distribut
infecti
dromedari
conduct
qualit
synthesi
studi
find
consid
report
heterogen
summaris
result
longitudin
studi
infect
immun
aim
assess
extent
current
understand
merscov
epidemiolog
dromedari
implic
control
gap
address
go
forward
note
similar
systemat
review
literatur
may
unknowingli
carri
parallel
discuss
two
group
confirm
updat
result
parallel
review
discuss
result
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
g
studi
also
test
differ
sitetyp
measur
rna
serum
sampl
rather
nasal
swab
includ
h
rang
across
week
rather
region
report
rna
preval
studi
j
unclear
whether
studi
found
neg
camel
mention
camel
test
found
posit
viral
genom
isol
test
limit
subset
sampl
use
detect
presenc
high
titr
posit
cutoff
titr
given
sampl
incred
high
titr
abl
neutralis
dilut
although
merscov
seropreval
consist
high
across
west
north
east
africa
middl
east
countri
level
studi
measur
consider
withincountri
variat
seropreval
particularli
africa
rang
given
tabl
kenya
three
studi
present
subnat
disaggreg
result
show
seropreval
vari
greatli
provinc
tunisia
morocco
mali
also
show
consider
region
seropreval
variat
less
region
variat
seropreval
observ
within
sever
studi
found
import
anim
significantli
higher
seropreval
local
bred
counterpart
dromedari
sampl
market
abattoir
quarantin
site
higher
seropreval
farm
villag
research
facil
case
dromedari
origin
vari
type
site
sampl
suggest
confound
studi
conduct
across
burkina
faso
morocco
ethiopia
dromedari
use
milk
meat
higher
seropreval
use
transport
studi
stratifi
sex
littl
differ
seen
kenya
femal
statist
significantli
higher
seropreval
male
vs
one
studi
vs
wherea
male
significantli
higher
seropreval
egypt
ksa
male
vs
femal
larg
medium
herdsiz
signific
risk
factor
seroposit
across
burkina
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
posit
merscov
rna
rang
day
across
publish
studi
posit
anim
becom
neg
within
week
avail
studi
follow
anim
found
merscov
rna
posit
first
instanc
sampl
durat
shed
prior
sampl
unknown
intermitt
rna
shed
evid
potenti
rapid
reinfectioncoinfect
observ
three
studi
found
dromedari
shed
merscov
rna
despit
high
antibodi
titr
month
week
prior
detect
infect
older
anim
whose
antibodi
reflect
past
exposur
young
calv
whose
high
antibodi
titr
maternallyacquir
immedi
postpartum
becam
infect
one
studi
directli
observ
recur
infect
amongst
herd
dromedari
egypt
four
anim
shed
month
prior
herdwid
epidem
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
agedepend
seropreval
pattern
suggest
higher
preval
viral
shed
juvenil
compar
adult
like
due
immunolog
naiveti
distribut
report
infect
synthesis
suggest
contact
juvenil
may
pose
greater
risk
human
transmiss
adult
make
potenti
target
vaccin
howev
frequenc
human
contact
dromedari
may
also
anim
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
seroposit
samplesit
type
sampl
popul
characterist
studi
report
latter
two
variabl
associ
statist
signific
differ
seropreval
preval
infect
within
individu
studi
heterogen
made
quantit
pool
inappropri
avail
studi
includ
camel
dens
region
northern
africa
rajasthan
india
yemen
addit
countri
includ
systemat
review
publish
literatur
oie
receiv
report
rna
posit
camel
iran
kuwait
technic
work
group
report
must
address
obtain
clearer
pictur
optim
vaccin
strategi
would
involv
well
like
impact
implement
consid
respiratori
syndrom
coronaviru
specif
antibodi
natur
expos
isra
llama
alpaca
camel
one
health
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
